Transplantační medicína

Keep scrolling to explore ACS updates

Keep scrolling to explore ACS updates

Keep scrolling to explore ACS updates

Learn more about SoliSimplify study and SoliPersistence study 

Evolving strategies for type 2 diabetes management filmed at the Australian Diabetes Congress, 20 August 2025

Evolving strategies for type 2 diabetes management filmed at the Australian Diabetes Congress, 20 August 2025

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).^1-5

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).^1-5

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).^1-5

Patients reported significant quality of life (QoL) challenges related to their ITP¹

Patients reported significant quality of life (QoL) challenges related to their ITP¹

Patients reported significant quality of life (QoL) challenges related to their ITP¹